Home > Insider Trading > Filing (0001567619-21-014785)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1035267	Intuitive Surgical Inc	ISRG	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	770416458

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1519593	J. David Rosa	1020 Kifer Road Sunnyvale CA 94086	Evp & Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-05	10,500	$172.44	43,212	No	4	M	Direct
Common Stock	Disposition	2021-08-05	8,146	$1,007.23	35,066	No	4	S	Direct
Common Stock	Acquisiton	2021-08-06	10,500	$172.44	45,566	No	4	M	Direct
Common Stock	Disposition	2021-08-06	8,065	$1,011.90	37,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-08-05	10,500	$0.00	10,500	$172.44
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-08-06	10,500	$0.00	10,500	$172.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,500		2022-08-15	No	4	M	Direct
0		2022-08-15	No	4	M	Direct

Footnotes

These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13, 2022.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $997.81 to $1,009.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,007.24 to $1,020.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.